Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 18 - Number 25




Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier

, 18(25): 3645 - 3648

Ji Hae Seo, Shuzhen Guo, Josephine Lok, Deepti Navaratna, Michael J. Whalen, Kyu-Won Kim and Eng H. Lo


DOI: 10.2174/138161212802002742




Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection

, 18(25): 3663 - 3669

Naoki Tajiri, Tsz Lau, Loren E. Glover, Kazutaka Shinozuka, Yuji Kaneko, Harry van Loveren and Cesar V. Borlongan


DOI: 10.2174/138161212802002724






Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke

, 18(25): 3704 - 3720

Xiaoming Hu, Meijuan Zhang, Rehana K Leak, Yu Gan, Peiying Li, Yanqin Gao and Jun Chen


DOI: 10.2174/138161212802002715



Cell Therapy for Stroke: Emphasis on Optimizing Safety and Efficacy Profile of Endothelial Progenitor Cells

, 18(25): 3731 - 3734

Yuji Kaneko, Naoki Tajiri, Kazutaka Shinozuka, Loren E. Glover, Nathan L. Weinbren, Lourdes Cortes and Cesar V. Borlongan


DOI: 10.2174/138161212802002733







Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance

, 18(25): 3784 - 3792

Arne R.M. van der Bilt, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Steven de Jong, Hetty Timmer- Bosscha, Klaske A. ten Hoor, Wilfred F.A. den Dunnen, Harry Hollema and Anna K.L. Reyners


DOI: 10.2174/138161212802002661


Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

, 18(25): 3793 - 3803

Stefaan Mulier, Jean-Pierre Claes, Vincent Dierieck, Jean-Olivier Amiel, Jean-Philippe Pahaut, Luc Marcelis, Fabienne Bastin, Denis Vanderbeeken, Claude Finet, Sophie Cran and Thierry Velu


DOI: 10.2174/138161212802002616




Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

, 18(25): 3816 - 3827

Eveline M. Dijkgraaf, Marij J.P. Welters, Johan W.R. Nortier, Sjoerd H. van der Burg and Judith R. Kroep


DOI: 10.2174/138161212802002797



Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog